SCHEMBL18009461

SCHEMBL18009461

COC(=O)/C=C/C(=O)O[C@@H]1C[C@@H](C(N)=O)N(C(=O)c2ccccc2)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CTSK P43235 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ PARP1 P09874 1/20 0.36
▸ PARP15 Q460N3 1/20 0.36
▸ PARP14 Q460N5 1/20 0.36
▸ PARP10 Q53GL7 1/20 0.36
▸ MMP2 P08253 1/20 0.36
▸ SPHK2 Q9NRA0 1/20 0.36
▸ SPHK1 Q9NYA1 1/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ SIRT3 Q9NTG7 1/20 0.35
▸ ABCB1 P08183 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ PLA2G1B P04054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18009292 0.91 PIK3CD (0.41) PIK3CDTSHRRECQLSMN1; SMN2CTSK
SCHEMBL18009294 0.90 MMP2 (0.46) PIK3CDTSHRRECQLSMN1; SMN2CTSK
SCHEMBL18007451 0.87 PIK3CD (0.39) PIK3CDTSHRRECQLSMN1; SMN2CTSK
SCHEMBL18009300 0.85 PIK3CD (0.42) PIK3CDTSHRRECQLSMN1; SMN2CTSK
SCHEMBL18009283 0.85 ALDH1A1 (0.40) PIK3CDTSHRRECQLSMN1; SMN2ALDH1A1
SCHEMBL18007448 0.84 MEN1 (0.38) PIK3CDTSHRRECQLSMN1; SMN2CTSK
SCHEMBL18009462 0.82 HPGD (0.40) PIK3CDTSHRRECQLSMN1; SMN2CTSK
SCHEMBL18007444 0.82 TSHR (0.41) TSHRRECQLSMN1; SMN2ALDH1A1MAPT
SCHEMBL18007443 0.81 MMP2 (0.36) PIK3CDTSHRRECQLSMN1; SMN2CTSK
SCHEMBL18007449 0.81 PIK3CD (0.36) PIK3CDTSHRRECQLSMN1; SMN2CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016127186-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2016-08-11 — — WO disclosed
Send feedback